Search
for
Sort by
Research 691–720 of 921
- Surgical Management of Scarring Alopecia
- Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris
- A case study of using cross-linked hyaluronic acid for upper eyelid rejuvenation
- Hair Transplantation
- Hair Transplantation
- Observation and consideration on using of JAKi in clinical trials in times of COVID ‐19
- Most Common Patient Hair Questions and Answers
- New Drugs for Alopecias
- Frontal fibrosing alopecia: follow-up of a brazilian group
- The Role of Hair Transplantation for Managing Facial Trauma
- Application and Approach to Hair Transplantation in Females
- Latanoprost-Loaded Nanotransfersomes Designed for Scalp Administration Enhance Keratinocytes Proliferation
- Frontal fibrosing alopecia in males: A systematic review
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Androgenetic Alopecia: An Update of Treatment Options
- Overview of Alopecia Areata
- Hox in hair growth and development
- Friction and wear studies of human hair and skin
- Alopecia Areata: An Updated Review for 2023
- Changing Patterns of Localization of Putative Stem Cells in Developing Human Hair Follicles
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Aging of the hair follicle pigmentation system
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work
- Genetic interplays between Msx2 and Foxn1 are required for Notch1 expression and hair shaft differentiation
- A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin
- The RAIG Family Member, GPRC5D, Is Associated with Hard-Keratinized Structures
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?